| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | — |
| R&D Expense | $59.0M | -16.9% |
| SG&A Expense | $21.4M | +62.7% |
| Operating Income | -$71.6M | +15.0% |
| Net Income | -$70.8M | +14.3% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.1M | -41.0% |
| Short-term Investments | $0 | — |
| Current Assets | $119.5M | +19.4% |
| Total Assets | $129.6M | +17.3% |
| Current Liabilities | $26.7M | +120.1% |
| Total Liabilities | $34.4M | +47.7% |
| Stockholders' Equity | $95.2M | +9.2% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.7M | -35.9% |
| Capital Expenditures | $1.3M | +57.3% |
| Investing Cash Flow | -$57.1M | -5952.8% |
| Financing Cash Flow | $71.1M | +10.6% |
| Free Cash Flow | -$55.0M | -36.3% |